GB1469908A - Preparation containing an enzyme for removal of anti-complement from gamma globulin - Google Patents
Preparation containing an enzyme for removal of anti-complement from gamma globulinInfo
- Publication number
- GB1469908A GB1469908A GB1507475A GB1507475A GB1469908A GB 1469908 A GB1469908 A GB 1469908A GB 1507475 A GB1507475 A GB 1507475A GB 1507475 A GB1507475 A GB 1507475A GB 1469908 A GB1469908 A GB 1469908A
- Authority
- GB
- United Kingdom
- Prior art keywords
- eliminated
- globulins
- april
- treated
- complement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010074605 gamma-Globulins Proteins 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 230000002391 anti-complement effect Effects 0.000 title 1
- 108010008730 anticomplement Proteins 0.000 title 1
- 239000002244 precipitate Substances 0.000 abstract 3
- 239000000047 product Substances 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- YPQQCGIIMOFILY-UHFFFAOYSA-N acridine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1=CC=CC2=CC3=CC=CC=C3N=C21 YPQQCGIIMOFILY-UHFFFAOYSA-N 0.000 abstract 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 239000001166 ammonium sulphate Substances 0.000 abstract 1
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 1
- 230000003171 anti-complementary effect Effects 0.000 abstract 1
- 239000000440 bentonite Substances 0.000 abstract 1
- 229910000278 bentonite Inorganic materials 0.000 abstract 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7413019A FR2267115B1 (OSRAM) | 1974-04-12 | 1974-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1469908A true GB1469908A (en) | 1977-04-06 |
Family
ID=9137624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1507475A Expired GB1469908A (en) | 1974-04-12 | 1975-04-11 | Preparation containing an enzyme for removal of anti-complement from gamma globulin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4137222A (OSRAM) |
| JP (1) | JPS5529053B2 (OSRAM) |
| AR (1) | AR205926A1 (OSRAM) |
| BE (1) | BE827852A (OSRAM) |
| BR (1) | BR7502230A (OSRAM) |
| CA (1) | CA1050885A (OSRAM) |
| DE (1) | DE2515666C3 (OSRAM) |
| DK (1) | DK139659B (OSRAM) |
| ES (1) | ES436525A1 (OSRAM) |
| FR (1) | FR2267115B1 (OSRAM) |
| GB (1) | GB1469908A (OSRAM) |
| LU (1) | LU72273A1 (OSRAM) |
| NL (1) | NL7504365A (OSRAM) |
| NO (1) | NO143478C (OSRAM) |
| SE (1) | SE403705B (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4439421A (en) * | 1982-08-30 | 1984-03-27 | Baxter Travenol Laboratories, Inc. | Stabilized gamma globulin concentrate |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK144731C (da) | 1976-07-30 | 1982-10-18 | Nordisk Insulinlab | Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev |
| US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
| DE2837168A1 (de) * | 1978-08-25 | 1980-03-06 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung |
| FR2556219B1 (fr) * | 1983-12-07 | 1987-06-26 | Merieux Inst | Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines |
| IL149687A0 (en) * | 2002-05-15 | 2002-11-10 | Alexander Condrea | Cervical dilator |
| US20090123560A1 (en) * | 2005-09-16 | 2009-05-14 | Kenji Yoshida | Hematopoietic Stem Cell Proliferation Inducing Agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK79841C (da) * | 1952-08-04 | 1955-09-12 | Behringwerke Ag | Fremgangsmåde til fremstilling af stabile γ-globulinpræparater. |
| US2922745A (en) * | 1958-01-10 | 1960-01-26 | Ortho Pharma Corp | Purification of profibrinolysin |
| NL286954A (OSRAM) * | 1962-01-03 | |||
| US3382227A (en) * | 1967-01-30 | 1968-05-07 | Pentex Inc | Blood protein fractionation employing 2-ethoxy-6, 9-diamino-acridine-lactate |
| BE789523A (fr) * | 1971-09-29 | 1973-03-29 | Behringwerke Ag | B1-glycoproteine specifique de la grossesse et son procede d'isolement |
| US3763135A (en) * | 1971-11-08 | 1973-10-02 | Baxter Laboratories Inc | Gamma globulin production from cohn fraction iii using polyethylene glycol |
| US3808124A (en) * | 1972-04-14 | 1974-04-30 | American Cyanamid Co | Purification of human plasminogen |
| US3943245A (en) * | 1974-02-14 | 1976-03-09 | Armour Pharmaceutical Company | Purification of plasminogen |
-
1974
- 1974-04-12 FR FR7413019A patent/FR2267115B1/fr not_active Expired
-
1975
- 1975-01-01 AR AR258335A patent/AR205926A1/es active
- 1975-04-10 DE DE2515666A patent/DE2515666C3/de not_active Expired
- 1975-04-11 US US05/567,403 patent/US4137222A/en not_active Expired - Lifetime
- 1975-04-11 BE BE155338A patent/BE827852A/xx not_active IP Right Cessation
- 1975-04-11 NL NL7504365A patent/NL7504365A/xx not_active Application Discontinuation
- 1975-04-11 SE SE7504196A patent/SE403705B/xx not_active IP Right Cessation
- 1975-04-11 ES ES436525A patent/ES436525A1/es not_active Expired
- 1975-04-11 JP JP4343875A patent/JPS5529053B2/ja not_active Expired
- 1975-04-11 NO NO751295A patent/NO143478C/no unknown
- 1975-04-11 BR BR2837/75A patent/BR7502230A/pt unknown
- 1975-04-11 CA CA224,575A patent/CA1050885A/fr not_active Expired
- 1975-04-11 GB GB1507475A patent/GB1469908A/en not_active Expired
- 1975-04-11 LU LU72273A patent/LU72273A1/xx unknown
- 1975-04-11 DK DK158075AA patent/DK139659B/da not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4439421A (en) * | 1982-08-30 | 1984-03-27 | Baxter Travenol Laboratories, Inc. | Stabilized gamma globulin concentrate |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2515666A1 (de) | 1975-10-23 |
| NL7504365A (nl) | 1975-10-14 |
| ES436525A1 (es) | 1977-01-01 |
| NO751295L (OSRAM) | 1975-10-14 |
| SE7504196L (sv) | 1975-10-13 |
| FR2267115A1 (OSRAM) | 1975-11-07 |
| NO143478C (no) | 1981-02-25 |
| NO143478B (no) | 1980-11-17 |
| DK158075A (OSRAM) | 1975-10-13 |
| CA1050885A (fr) | 1979-03-20 |
| BE827852A (fr) | 1975-10-13 |
| SE403705B (sv) | 1978-09-04 |
| DE2515666B2 (de) | 1979-10-18 |
| DE2515666C3 (de) | 1980-06-26 |
| US4137222A (en) | 1979-01-30 |
| DK139659B (da) | 1979-03-26 |
| FR2267115B1 (OSRAM) | 1977-11-10 |
| JPS5529053B2 (OSRAM) | 1980-07-31 |
| DK139659C (OSRAM) | 1979-09-17 |
| LU72273A1 (OSRAM) | 1975-08-20 |
| BR7502230A (pt) | 1976-02-10 |
| JPS50145517A (OSRAM) | 1975-11-21 |
| AR205926A1 (es) | 1976-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1441751A (en) | Purification of albumin by thermocoagulation | |
| AT340605B (de) | Verfahren zur herstellung neuer amidderivate von vinblastin, leurosidin und leurocristin und ihrer saureadditionssalze | |
| GB1495159A (en) | Process reducing the anticomplementary activity of gamma globulins | |
| GB1431288A (en) | Method for removing water from a mixture comprising solid matter and water | |
| GB1469908A (en) | Preparation containing an enzyme for removal of anti-complement from gamma globulin | |
| ATE65250T1 (de) | Verfahren zur herstellung von sehr reinem dermatansulfat und pharmazeutische zusammensetzungen, welche dieses enthalten. | |
| IE42521L (en) | Treating a sodium lauryl sulphate-whey protein complex. | |
| GB1167993A (en) | Novel Chemical Compounds, Process for Making Same and Method of Treatment | |
| GB1492959A (en) | Process for obtaining a plasminogen activator | |
| GB1186544A (en) | Immunological Reagent and the Production Thereof | |
| GB1528259A (en) | Process for the preparation of a gamma-globulin solution suitable for intravenous administration | |
| GB1525084A (en) | Cyanuric acid manufacture | |
| GB1441752A (en) | Preparation of human or other purified albumin | |
| MURAOKA et al. | Isolation of ferritin crystal from rabbit liver and spleen | |
| GB1446789A (en) | Production of benzenesulphonamides | |
| GB1475262A (en) | Human urinary trypsin inhibitor and a method of preparing it | |
| GB1161722A (en) | Improvements in or relating to the Preparation of Enzyme Solutions | |
| GB1313926A (en) | Preparation of potassium nitrate | |
| GB535089A (en) | Purification of antibody compositions | |
| GB1263677A (en) | Process for the preparation of quinoxaline-di-n-oxide-aldehyde | |
| ES406976A1 (es) | Procedimiento para el aislamiento de una nueva beta1-glico-proteina especifica para el embarazo. | |
| GB1204534A (en) | Process for the purification of sewage | |
| SU1091512A1 (ru) | Способ получения 2-амидинотиомочевины | |
| ES433772A1 (es) | Procedimiento de fabricacion de un extracto biologico ac- tivo aplicable a la terapia relacionada con el sistema con- juntivo. | |
| GB1384849A (en) | Process for obtaining pepsin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930411 |